Daily non-political popular news in brief.

Cellulose nanocrystal research could lead to new vaccines, computer inks

A wood scientist is attaching antibodies to the surface of cellulose crystals. This design enables the nanocrystals to block cell receptors in the body. The process may eventually be used to create vaccines. Through the same receptor-blocking method, this process can combat the effects of some diseases involving inflammation of blood vessels, including diabetes, rheumatoid arthritis and certain cancers.

Read more »

Keywords: cellulose, nanocrystal, research, lead, vaccines, computer, inks, vaccine, ink

« Previous | Next »

Similar news on "Cellulose nanocrystal research could lead to new vaccines, computer inks":

1. Phase III trials of cellulose sulfate microbicide for HIV prevention closed
   01-31-2007 · EurekAlert!
   CONRAD, a reproductive health research organization, announced today that it has halted a Phase III clinical trial of cellulose sulfate -- a topical microbicide gel being tested for HIV prevention in women -- because preliminary results indicated that cellulose sulfate could lead to an increased risk of HIV infection in women who use the compound. The trial was being conducted in South Africa, Benin, Uganda, and India.
   Similar news · Read more »
   
2. The CReSA is working on a new strategy to combat spongiforms
   10-31-2006 · EurekAlert!
   Researchers at the Animal Health Research Centre (CReSA) are developing immunotherapeutical strategies against diseases produced by prion, such as Bovine Spongiform Encephalitis. The most recent results, published in the Journal of Virology, show that important advances have been made in tests using DNA vaccines on animal models, enabling a significant delay in the arrival of symptoms. In the long term, this research could lead to the production of treatment for humans.
   Similar news · Read more »
   
3. Sharks' 'bite force' researched by University of Tampa biologist
   08-23-2007 · EurekAlert!
   Dan Huber, University of Tampa assistant professor of biology, is analyzing the "bite force" and feeding mechanics of great white sharks. Earlier this summer Huber traveled to Australia to dissect a rare 8-foot great white shark, and help create the first high-res 3-D computer model of its bite. Huber's research may lead to advances in protective swimwear, shark-proofing equipment and a better understanding of flexible cartilage -- which forms the sharks' whole skeletons.
   Similar news · Read more »
   
4. Pancreatic cancer vaccine halts progression of disease in some patients
   04-17-2007 · EurekAlert!
   A dendritic cell-based therapeutic vaccine for pancreatic cancer developed by researchers at the University of Pittsburgh School of Medicine has successfully stalled the disease from progressing in a handful of patients three years post-vaccination. The results, part of a press briefing on cancer vaccines held at the annual meeting of the American Association of Cancer Research, provide promising evidence that the vaccine can trigger a patient's own immune system to rally against pancreatic cancer.
   Similar news · Read more »
   
5. Emerging research heralds new era of breast cancer management
   02-12-2007 · EurekAlert!
   Aggressive research currently underway brings hope of dramatic advances in breast cancer management, according to a new review. The review reveals that new approaches in breast cancer imaging, investigations into the timing of chemotherapy and research on breast cancer vaccines may lead to exciting new nonsurgical tools for the physician treating breast cancer patients.
   Similar news · Read more »
   
6. Head and neck cancer vaccine targets proteins to create immune response
   04-17-2007 · EurekAlert!
   Researchers at the University of Pittsburgh Cancer Institute, in collaboration with the Gunma University School of Medicine in Japan, have developed a vaccine strategy for head and neck cancer that targets multiple peptides to activate the immune system to attack tumors. Their findings will be included in a press briefing on cancer vaccines at the annual meeting of the American Association for Cancer Research, April 14-18, at the Los Angeles Convention Center.
   Similar news · Read more »
   
7. UQ research heralds vaccine technology breakthrough
   05-07-2007 · EurekAlert!
   New Queensland research may lead to a groundbreaking vaccine technology that couldwipe out an infection that commonly affects young children.
   Similar news · Read more »
   
8. Biodegradable microspheres deliver time release vaccines, stimulate different immune response
   02-28-2007 · EurekAlert!
   A new vaccine delivery system using microspheres of a biodegradable polymer may not only reduce the need for booster shots in some cases, but also appears to stimulate an immune response that traditional vaccines do not. Researchers from Iowa State University report their findings today at the ASM Biodefense and Emerging Disease Research Meeting.
   Similar news · Read more »
   
9. New target for HIV/AIDS drugs and vaccine discovered
   07-26-2007 · EurekAlert!
   Researchers from Rome, Italy, describe a finding in the August 2007 print issue of the FASEB Journal that could lead to new drugs to fight the HIV/AIDS virus, as well as new vaccines to prevent infection. In this report, researchers demonstrate for the first time how the HIV-1 Nef viral protein delivers a one-two punch to the body's innate immune system.
   Similar news · Read more »
   
10. Babies excrete vaccine-mercury quicker than originally thought
    01-30-2008 · EurekAlert!
    February's issue of Pediatrics offers another reason to rethink blaming the spike in autism diagnoses on thimerosal, a mercury-containing preservative routinely used in several childhood vaccines until the late '90s. New research from the University of Rochester suggests that infants' bodies expel the thimerosal mercury much faster than originally thought -- thereby leaving little chance for a progressive building up of the toxic metal.
    Similar news · Read more »